All tagged pfizer

Wait time for Moderna COVID-19 booster shortened to five months

The FDA now authorizes and the Centers for Disease Control and Prevention recommends individuals who received the Moderna COVID-19 vaccine get a booster dose after five months. This announcement from federal agencies comes just three days after the announcement of a shortened wait time for a booster from six months to five months for individuals who received the Pfizer vaccine.

FDA authorizes first oral antiviral for treatment of COVID-19

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death

Health experts warn of significant impact from Omicron variant of COVID-19; NCDHHS urges everyone to get vaccinated

Health experts are warning that the highly contagious COVID-19 variant, Omicron, is expected to cause the greatest surge in COVID-19 infections to date in the coming months. The CDC and NCDHHS urge people to get vaccinated with an mRNA vaccine (Pfizer or Moderna) as soon as possible and to get a booster as soon as they are eligible to help prevent serious illness, hospitalization and death.

FDA and CDC Authorize Pfizer COVID-19 Vaccine for Children Age 12 and Older

Based on a review of safety and effectiveness data from clinical trials in the United States and the expanded emergency authorization by the U.S. Food and Drug Administration, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) and the CDC today recommended use of Pfizer’s COVID-19 vaccine for children ages 12 through 15.